Dr. Jung’s Story

Treating pediatric uveitis, a serious eye inflammation, requires potent steroids like difluprednate. Despite urgent need, insurance denied it, mandating futile trial of weaker drops. Patient’s condition worsened, necessitating oral steroids with adverse effects. Insurance-induced delays led to demoralizing battles, undermining care quality. As a dedicated practitioner, advocating for patients becomes exhausting amidst administrative obstacles. These unnecessary hurdles fuel burnout, detracting from delivering optimal care despite years of training.